EU Agency: ‘Possible Link’ Between AstraZeneca Vaccine and Rare Blood Clots

THE EUROPEAN UNION'S drug agency said Wednesday that there is a "possible link" between the AstraZeneca coronavirus vaccine and rare blood clots, but it added that "the overall benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects." The European Medicines Agency's safety committee recommended that blood clots should be listed as a "very rare" side effect of the vaccine.
Read more...

;